Literature DB >> 26718349

The Effectiveness of Zolpidem for the Treatment of Disorders of Consciousness.

Calvin Tucker1, Kirsten Sandhu2.   

Abstract

Approximately, five million people in the United States live with the residual effects of brain injury. The causes of acquired brain injury can be categorized as traumatic brain injury or non-traumatic brain injury. There are currently no treatments shown to consistently enhance recovery from disorders of consciousness (DOC). Sporadic recovery from DOC after the administration of various pharmacological agents has been described in several case reports. Increase in arousal after zolpidem administration is seen in patients with vegetative state or minimally conscious state for treatment of restlessness and disturbances of their sleep-wake cycle. The use of zolpidem could be reasonable in select patients with neurologic injury but promising integrity of brain structures, such as intact deep and superficial gray matter structures and white matter connections.

Entities:  

Keywords:  Arousal; Consciousness; Zolpidem

Mesh:

Substances:

Year:  2016        PMID: 26718349     DOI: 10.1007/s12028-015-0227-5

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  21 in total

1.  Recovery of consciousness after severe brain injury: the role of arousal regulation mechanisms and some speculation on the heart-brain interface.

Authors:  Nicholas D Schiff
Journal:  Cleve Clin J Med       Date:  2010-07       Impact factor: 2.321

2.  Drug induced arousal from the permanent vegetative state.

Authors:  Ralf Clauss; Wally Nel
Journal:  NeuroRehabilitation       Date:  2006       Impact factor: 2.138

3.  Zolpidem and its effects on hypoxic encephalopathy.

Authors:  Y L Lo; E K Tan; P Ratnagopal; L L Chan; T E Tan
Journal:  Ann Neurol       Date:  2008-10       Impact factor: 10.422

4.  Differential profiles for patients with traumatic and non-traumatic brain injury.

Authors:  Angela Colantonio; Gary Gerber; Mark Bayley; Raisa Deber; Junlang Yin; Hwan Kim
Journal:  J Rehabil Med       Date:  2011-03       Impact factor: 2.912

Review 5.  Awakenings and awareness recovery in disorders of consciousness: is there a role for drugs?

Authors:  Francesca Pistoia; Elisa Mura; Stefano Govoni; Massimo Fini; Marco Sarà
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

Review 6.  Recovery of consciousness after brain injury: a mesocircuit hypothesis.

Authors:  Nicholas D Schiff
Journal:  Trends Neurosci       Date:  2009-12-01       Impact factor: 13.837

Review 7.  Disorders of consciousness after acquired brain injury: the state of the science.

Authors:  Joseph T Giacino; Joseph J Fins; Steven Laureys; Nicholas D Schiff
Journal:  Nat Rev Neurol       Date:  2014-01-28       Impact factor: 42.937

8.  Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial.

Authors:  John Whyte; Robin Myers
Journal:  Am J Phys Med Rehabil       Date:  2009-05       Impact factor: 2.159

9.  Common resting brain dynamics indicate a possible mechanism underlying zolpidem response in severe brain injury.

Authors:  Shawniqua T Williams; Mary M Conte; Andrew M Goldfine; Quentin Noirhomme; Olivia Gosseries; Marie Thonnard; Bradley Beattie; Jennifer Hersh; Douglas I Katz; Jonathan D Victor; Steven Laureys; Nicholas D Schiff
Journal:  Elife       Date:  2013-11-19       Impact factor: 8.140

10.  Changes in cerebral metabolism in patients with a minimally conscious state responding to zolpidem.

Authors:  Camille Chatelle; Aurore Thibaut; Olivia Gosseries; Marie-Aurélie Bruno; Athena Demertzi; Claire Bernard; Roland Hustinx; Luaba Tshibanda; Mohamed A Bahri; Steven Laureys
Journal:  Front Hum Neurosci       Date:  2014-12-02       Impact factor: 3.169

View more
  4 in total

Review 1.  Clinical Decision on Disorders of Consciousness After Acquired Brain Injury: Stepping Forward.

Authors:  Rui-Zhe Zheng; Zeng-Xin Qi; Zhe Wang; Ze-Yu Xu; Xue-Hai Wu; Ying Mao
Journal:  Neurosci Bull       Date:  2022-07-08       Impact factor: 5.203

2.  EEG Evidence Reveals Zolpidem-Related Alterations and Prognostic Value in Disorders of Consciousness.

Authors:  Zexuan Hao; Xiaoyu Xia; Yang Bai; Yong Wang; Weibei Dou
Journal:  Front Neurosci       Date:  2022-04-27       Impact factor: 5.152

3.  Therapies to Restore Consciousness in Patients with Severe Brain Injuries: A Gap Analysis and Future Directions.

Authors:  Brian L Edlow; Leandro R D Sanz; Robert D Stevens; Olivia Gosseries; Len Polizzotto; Nader Pouratian; John D Rolston; Samuel B Snider; Aurore Thibaut
Journal:  Neurocrit Care       Date:  2021-07-08       Impact factor: 3.210

4.  Combined Behavioral and Mismatch Negativity Evidence for the Effects of Long-Lasting High-Definition tDCS in Disorders of Consciousness: A Pilot Study.

Authors:  Xiaoyu Wang; Yongkun Guo; Yunge Zhang; Jinju Li; Zhongqi Gao; Yingxin Li; Tianlin Zhou; Hui Zhang; Jianghong He; Fengyu Cong
Journal:  Front Neurosci       Date:  2020-04-28       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.